OTR Therapeutics: Valuation, Funding & Investors
OTR Therapeutics is a biotechnology company dedicated to transforming early-stage innovations into globally impactful therapies for critical diseases with high unmet medical needs. With a strategic focus on oncology, immunology and inflammation, and cardiometabolic diseases, the company discovers and acquires distinctive assets in preclinical and early clinical stages, accelerating their development into differentiated, clinically impactful treatments.
Leadership & Board
- Current Number of Employees
- 11
- Current LinkedIn Followers
- 673
Latest Estimated Valuation
- Total Amount Raised
- $100M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $100M
- Latest Funding Round
- Series A
Employee Trend
OTR Therapeutics had 11 employees as of October 26, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
OTR Therapeutics had 673 followers as of October 26, 2026. The number of followers increased by 1 (0.15%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Dec 05, 2025 | Series A | $100.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Pfizer Ventures | Series A |
| Sirona Capital | Series A |
| LAV | Series A |
| True Light Capital | Series A |
Similar Companies
A snapshot of private companies similar to OTR Therapeutics, helping you discover and navigate related company profiles.
Related News and Analysis
